{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:05:59Z","timestamp":1793023559678,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.tranon.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T16:44:08Z","timestamp":1560271448000},"page":"1131-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma"],"prefix":"10.1016","volume":"12","author":[{"given":"Riuko","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schraml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashil","family":"Batavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Angori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Simmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ajioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tranon.2019.05.005_bb0005","article-title":"Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability","author":"Paolella","year":"2017","journal-title":"elife"},{"key":"10.1016\/j.tranon.2019.05.005_bb0010","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2012.07.023","article-title":"Cancer vulnerabilities unveiled by genomic loss","volume":"150","author":"Nijhawan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2019.05.005_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02890129","article-title":"Human chromophobe cell renal carcinoma","volume":"48","author":"Thoenes","year":"1985","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.tranon.2019.05.005_bb0020","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer","author":"Moch","year":"2016"},{"key":"10.1016\/j.tranon.2019.05.005_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10690.x","article-title":"Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series","volume":"110","author":"Volpe","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.tranon.2019.05.005_bb0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.tranon.2019.05.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92688","article-title":"Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma","volume":"2","author":"Casuscelli","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tranon.2019.05.005_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2019.05.005_bb0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tranon.2019.05.005_bb0050","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1158\/0008-5472.CAN-17-0986","article-title":"HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas","volume":"77","author":"Sun","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2019.05.005_bb0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00428-017-2276-y","article-title":"Eighth Edition of the UICC classification of malignant tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?","volume":"472","author":"Bertero","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.tranon.2019.05.005_bb0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PAS.0000000000000456","article-title":"Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma","volume":"39","author":"Deml","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.tranon.2019.05.005_bb0065","first-page":"4244s","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"McCarty","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2019.05.005_bb0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/path.2310","article-title":"pVHL co-ordinately regulates CXCR4\/CXCL12 and MMP2\/MMP9 expression in human clear-cell renal cell carcinoma","volume":"214","author":"Struckmann","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.tranon.2019.05.005_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mrfmmm.2014.12.006","article-title":"Step-wise and punctuated genome evolution drive phenotype changes of tumor cells","volume":"771","author":"Stepanenko","year":"2015","journal-title":"Mutat Res"},{"key":"10.1016\/j.tranon.2019.05.005_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.tranon.2019.05.005_bb0085","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tranon.2019.05.005_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drudis.2012.07.013","article-title":"The development and application of small molecule modulators of SF3b as therapeutic agents for cancer","volume":"18","author":"Webb","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.tranon.2019.05.005_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrc.2016.51","article-title":"RNA splicing factors as oncoproteins and tumour suppressors","volume":"16","author":"Dvinge","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tranon.2019.05.005_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.tranon.2019.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/leu.2014.331","article-title":"Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells","volume":"29","author":"Dolatshad","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2019.05.005_bb0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2019.05.005_bb0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature14508","article-title":"HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease","volume":"522","author":"Mirtschink","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2019.05.005_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anndiagpath.2005.12.002","article-title":"Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases","volume":"10","author":"Hes","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.tranon.2019.05.005_bb0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1827.2008.02227.x","article-title":"Oncocytic renal cell carcinoma having papillotubular growth: rare morphological variant of papillary renal cell carcinoma","volume":"58","author":"Masuzawa","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.tranon.2019.05.005_bb0130","first-page":"1392","article-title":"Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features","volume":"6","author":"Xia","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"476508","key":"10.1016\/j.tranon.2019.05.005_bb0135","article-title":"Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms","volume":"2015","author":"Yap","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.tranon.2019.05.005_bb0140","first-page":"161","volume":"18","author":"Brunelli","year":"2005","journal-title":"Inc"},{"issue":"152","key":"10.1016\/j.tranon.2019.05.005_bb0145","article-title":"High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas","volume":"9","author":"Yusenko","year":"2009","journal-title":"BMC Cancer"},{"issue":"196","key":"10.1016\/j.tranon.2019.05.005_bb0150","article-title":"Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma","volume":"10","author":"Tan","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2019.05.005_bb0155","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0002-9440(10)65734-3","article-title":"Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes","volume":"153","author":"Jiang","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tranon.2019.05.005_bb0160","first-page":"27","article-title":"Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma","volume":"56","author":"Moch","year":"1996","journal-title":"Cancer Res"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523319301111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523319301111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:36:12Z","timestamp":1761834972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523319301111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1936523319301111"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2019.05.005","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}